Developing drugs which target metabolic pathways is a relatively new, exciting prospect in oncology and metabolism has been hailed the “Achilles’ heel” of cancer. Given the pharmaceutical industry’s heavy investment into the research of cancer metabolism, there has never been such a need for companies to come together to improve the future of cancer treatments with broad acting, potent drugs. The World Cancer Metabolism Summit will cover topics highlighted by industry leaders in the commercial drug development process; specific and relevant to cancer metabolism. With the agenda designed by recent research with experts at GSK, AstraZeneca, Genentech, Myrexis, Cornerstone Pharmaceuticals and Warburg Glycomed, it is built to reflect the current challenges the industry is facing, and drive businesses and drugs through the clinic and into the market. This meeting will directly help you to accelerate progress and overcome the many hurdles in pre-clinical and early clinical stages. This meeting will be your only to chance to hear from the industry leaders such as AstraZeneca, Warburg Glycomed and Myrexis about the approaches and strategies that they use when developing these drugs. You will learn how to make the most out of your research whilst building long-lasting business relationships through dedicated networking sessions. What’s on the agenda? You will hear from drug industry leaders and pioneering researchers from all over the world to learn about the latest approaches to increase your oncology drug programme’s chance of success. Here are just some of the topics that will be covered: * Explore the latest strategies in drug target identification to facilitate novel drug discovery * Overcome the challenge of metabolic redundancy with experts from the field * Find out how to use tumor models to accelerate your pre-clinical development * Learn to increase your patient populations and improve your selection techniques using the latest technologic advances * Address the best methods to ensure clinical success * Gain updates from the leading drug development programmes to gain valuable knowledge to take back to your lab Why attend? All sessions are designed to be 100% relevant for progressing your oncology pipelines. Uniquely you will receive personalized advice and guidance on achieving success in pre clinical and clinical development of metabolic targeting drugs. As well as our main programme, our pre-conference workshops are a fantastic chance to get the information and contacts you need through a small, high-level and interactive discussion. Location: Washington D.C.